510(k) Report

510(k) · Cleared

Cleared

Startox Drug of Abuse Screening Test (4)

K022388510(k) TraditionalCleared Feb 27, 2003219-day reviewClass II21 CFR 862.3610

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Starplex Scientific, Inc. · DJC Thin Layer Chromatography, Methamphetamine

Cleared on Feb 27, 2003 as substantially equivalent to K012159 (American Bio Medica Corp., 2001) and 1 other predicate after a 219-day review. Its family tree reaches back 1 generation to 2000.

Decided
Feb 27, 2003
Review
219 days
Class
Class II
Product code
DJC
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K002447 (2000). 2 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2001: 1 other ancestorK002447 · Modification to Rapid Drug Screen 9-Panel · American Bio Medica Corp. · 2000200020022004
Other ancestors, by generation 1 generation back: 1 other ancestor K002447 · Modification to Rapid Drug Screen 9-Panel · American Bio Medica Corp. · 20000
  1. Root · 1 generation backK002447 Modification to Rapid Drug Screen 9-PanelAmerican Bio Medica Corp. · 2000
  2. This deviceK022388 Startox Drug of Abuse Screening Test (4)Starplex Scientific, Inc. · 2003
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K002447Modification to Rapid Drug Screen 9-PanelAmerican Bio Medica Corp.2000—
0 (this device)K022388Startox Drug of Abuse Screening Test (4)Starplex Scientific, Inc.2003—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
FIG. 1 — Lineage of K022388, 2000–2003Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DJC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DJC device

  1. #1 K253705 Healgen® Accurate Oral Fluid Drug Testscore 12.2 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K012159Rapid Drug ScreenAmerican Bio Medica Corp.2001—
*K002447Modification to Rapid Drug Screen 9-Panel
Summary page 2
…rugs in human urine at the levels indicated. STARTOXTMis substantial equivalent to Rapid Drug Screen 9 panel manufactured by American BioMedica Corporation 5 10k number K002447. Product performance for Opiates, Cocaine and Cannabinoids was compared Medtox Profile 11 manufactured by Medtox Diagnostics. Pe…
American Bio Medica Corp.2000—

Also cleared against K012159: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • 2 other devices also cite its predicate K012159.

How does its category compare?

All DJC devices

DJC Thin Layer Chromatography, Methamphetamine: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DJC

1in 2025

2008: 12013: 12016: 12018: 32025: 12026 (partial year): 1
2007high 3 (2018) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DJC

258in 2018

2018: 258 days median
2007high 258 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DJC

No recall names DJC since 2007.

Adverse event reports per year · DJC

2in 2018

2017: 12018: 2
2007high 2 (2018) · low 0 (2007)2025

MAUDE reports naming product code DJC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20081—00
20090—00
20100—00
20110—00
20120—00
20131—00
20140—00
20150—00
20161—00
20170—01
2018325802
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20251—00
20261—0—

What is it indicated for?

“STARTOX” Drugs of Abuse Screening Test is a one-step lateral flow immunoassay intended for the simultaneous detection of multiple drug analytes in urine. “STARTOX” is intended for use in the qualitative detection of drugs of abuse at the following Substance Abuse Mental Health Services Administration (SAMHSA) recommended levels: Compound — Abbreviation — Level Methamphetamine ((+/-)methamphetamine HCI) — METH — 1000 ng/ml Opiates (morphine) — OPIATES —…

Read the full statement (140 words)

“STARTOX” Drugs of Abuse Screening Test is a one-step lateral flow immunoassay intended for the simultaneous detection of multiple drug analytes in urine. “STARTOX” is intended for use in the qualitative detection of drugs of abuse at the following Substance Abuse Mental Health Services Administration (SAMHSA) recommended levels:

Compound — Abbreviation — Level

Methamphetamine ((+/-)methamphetamine HCI) — METH — 1000 ng/ml

Opiates (morphine) — OPIATES — 300 ng/ml

Cocaine (benzoylecgonine) — COCAINE — 300 ng/ml

Cannabinoids (1l-nor-A9-THC-9-carboxylic-acid) — THC — 50 ng/ml

STARTOXTMDrugs of Abuse Screening Test provide only a preliminary qualitative test result. Use a more specific alternate quantitative analytical method to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GCMS) is the preferred confirmatory method. Apply clinical and professional judgment to any drug of abuse test result, particularly when preliminary positive results are obtained.

For professional use only.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K022388: Startox Drug of Abuse Screening Test (4).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K022388

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026